These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27442856)

  • 1. Pulmonary Hypertension in the Era of Mechanical Circulatory Support.
    Krishnamurthy Y; Cooper LB; Parikh KS; Felker GM; Milano CA; Rogers JG; Hernandez AF; Patel CB
    ASAIO J; 2016; 62(5):505-12. PubMed ID: 27442856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies.
    Haddad F; Kudelko K; Mercier O; Vrtovec B; Zamanian RT; de Jesus Perez V
    Prog Cardiovasc Dis; 2011; 54(2):154-67. PubMed ID: 21875514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations in the Diagnosis and Management of Pulmonary Hypertension Associated With Left Heart Disease.
    Ilonze OJ; Ebong IA; Guglin M; Nair A; Rich J; McLaughlin V; Tedford RJ; Mazimba S
    JACC Heart Fail; 2024 Aug; 12(8):1328-1342. PubMed ID: 38970588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary Hypertension in Advanced Heart Failure: Assessment and Management of the Failing RV and LV.
    Rao SD; Menachem JN; Birati EY; Mazurek JA
    Curr Heart Fail Rep; 2019 Oct; 16(5):119-129. PubMed ID: 31292856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular heart failure and pulmonary hypertension.
    Rosenkranz S; Gibbs JS; Wachter R; De Marco T; Vonk-Noordegraaf A; Vachiéry JL
    Eur Heart J; 2016 Mar; 37(12):942-54. PubMed ID: 26508169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension associated with left heart disease.
    Wissmüller M; Dohr J; Adler J; Ochs L; Tichelbäcker T; Hohmann C; Baldus S; Rosenkranz S
    Herz; 2023 Aug; 48(4):266-273. PubMed ID: 37289211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pulmonary hypertension associated with left heart disease (group 2)].
    Wissmüller M; Tichelbäcker T; Finke K; Dohr J; Adler J; Ochs L; Hohmann C; Baldus S; Rosenkranz S
    Dtsch Med Wochenschr; 2023 Nov; 148(23):1498-1506. PubMed ID: 37949078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of pulmonary hypertension in left heart disease.
    Schmeisser A; Schroetter H; Braun-Dulleaus RC
    Ther Adv Cardiovasc Dis; 2013 Jun; 7(3):131-51. PubMed ID: 23592742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of advanced group 2 PH.
    Barnett CF; De Marco T
    Prog Cardiovasc Dis; 2016; 59(1):78-86. PubMed ID: 27417251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models of pulmonary hypertension due to left heart disease.
    Liu SF; Yan Y
    Animal Model Exp Med; 2022 Sep; 5(3):197-206. PubMed ID: 35234367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary hypertension due to left heart disease: The prognostic implications of diastolic pulmonary vascular pressure gradient.
    Ibe T; Wada H; Sakakura K; Ikeda N; Yamada Y; Sugawara Y; Mitsuhashi T; Ako J; Fujita H; Momomura S
    J Cardiol; 2016 Jun; 67(6):555-9. PubMed ID: 26299611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left heart disease: a frequent cause of early pulmonary hypertension in systemic sclerosis, unrelated to elevated NT-proBNP levels or overt cardiac fibrosis but associated with increased levels of MR-proANP and MR-proADM: retrospective analysis of a French Canadian cohort.
    Miller L; Chartrand S; Koenig M; Goulet JR; Rich É; Chin AS; Chartrand-Lefebvre C; Abrahamowicz M; Senécal JL; Grodzicky T
    Scand J Rheumatol; 2014; 43(4):314-23. PubMed ID: 25089008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary Hypertension Due to Left Heart Disease: an Update.
    Aras MA; Psotka MA; De Marco T
    Curr Cardiol Rep; 2019 May; 21(7):62. PubMed ID: 31134443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical-imaging-pathological correlation in pulmonary hypertension associated with left heart disease.
    van de Veerdonk MC; Roosma L; Trip P; Gopalan D; Vonk Noordegraaf A; Dorfmüller P; Nossent EJ
    Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38417969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pulmonary hypertension – a common condition in left heart disease].
    Lundgren J; Rådegran G
    Lakartidningen; 2017 Dec; 114():. PubMed ID: 29292958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension due to left heart diseases.
    Vachiéry JL; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs JS; Martinez F; Semigran M; Simonneau G; Wells A; Seeger W
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D100-8. PubMed ID: 24355634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "From right to left": The role of right heart catheterization in the diagnosis and management of left heart diseases.
    Kałużna-Oleksy M; Araszkiewicz A; Migaj J; Lesiak M; Straburzyńska-Migaj E
    Adv Clin Exp Med; 2017; 26(1):135-141. PubMed ID: 28397445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Hypertension in Heart Failure Patients: Pathophysiology and Prognostic Implications.
    Guazzi M; Labate V
    Curr Heart Fail Rep; 2016 Dec; 13(6):281-294. PubMed ID: 27858232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update in approaches to pulmonary hypertension because of left heart disease.
    Kennedy JLW; Mihalek AD
    Curr Opin Pulm Med; 2022 Sep; 28(5):337-342. PubMed ID: 35838362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Challenges and Emerging Treatment Targets for Pulmonary Hypertension in Left Heart Disease.
    Lteif C; Ataya A; Duarte JD
    J Am Heart Assoc; 2021 Jun; 10(11):e020633. PubMed ID: 34032129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.